ALK alteration is a frequent event in aggressive breast cancersAbdul K. Siraj, Khawla S. Al‐Kuraya|Breast Cancer Research|2015Cited by 42
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E MutationAbdul K. Siraj, Khawla S. Al‐Kuraya|Cancers|2021Cited by 31
High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast CancerAbdul K. Siraj, Khawla S. Al‐Kuraya|OncoTargets and Therapy|2021Cited by 20
<i>MED12</i>is recurrently mutated in Middle Eastern colorectal cancerAbdul K. Siraj, Khawla S Al-Kuraya|Gut|2017Cited by 16
Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian CancerAbdul K. Siraj, Khawla S. Al‐Kuraya|Frontiers in Pharmacology|2020Cited by 8